G1 Therapeutics, Inc. (NASDAQ: GTHX) Q3 2023 Earnings Call Transcript November 1, 2023 G1 Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.35 EPS, expectations were $-0.31.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results